Dacomitinib free base ≥99% (by HPLC)
Supplier: Enzo Life Sciences
Synonyms:
(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide, (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide, PF 00299804
CHM221-0025
CHM221-0050
CHM221-0100
CHM221-0200
CHM221-0250
CHM221-0500
76203-182EA
392.4
USD
76203-182
76203-184
76203-186
76203-188
76203-190
76203-192
Dacomitinib free base ≥99% (by HPLC)
Dacomitinib
Dacomitinib is a potent, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity.
- Potent inhibitor of the EGFR family of tyrosine kinases
White solid.
Soluble in DMSO.
Formula:
C₂₄H₂₅ClFN₅O₂ MW: 469.95 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD19443734 CAS Number: 1110813-31-4 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...